CIK 0001357874 · Non-accelerated filer<br>Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- operating
- Phone
- 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-29 | Kelly John Alexander Chief Financial Officer | Grant or award | +506 | $18.50 | $9K | 20,978 |
| 2024-02-29 | SMITH J. JEFFERSON Chief Research Officer | Grant or award | +1,006 | $12.42 | $12K | 67,248 |
| 2024-01-22 | Amoroso Michael President and CEO | Sale 10b5-1 | −137,390 | $0.36 | $49K | 356,433 |
| 2024-01-22 | Scimeca Dario General Counsel and Secretary | Sale 10b5-1 | −21,287 | $0.36 | $8K | 151,028 |
| 2024-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise | +116,690 | 614,169 | ||
| 2024-01-20 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −116,690 | 233,310 | ||
| 2024-01-20 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +266,720 | 493,823 | ||
| 2024-01-20 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −266,720 | 533,280 | ||
| 2024-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +59,345 | 172,315 | ||
| 2024-01-20 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −59,345 | 118,655 |
Page 11 of 11 · 210 trades